Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
Open Access
- 6 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Psychiatry
- Vol. 11 (1), 190
- https://doi.org/10.1186/1471-244x-11-190
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physiciansBMC Neurology, 2011
- Diabetes prevalence based on health insurance claims: large differences between companiesDiabetic Medicine, 2011
- Specialist involvement and referral patterns in ambulatory medical care for patients with dementia in Germany: results of a claims data based case-control studyBMC Health Services Research, 2011
- Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohortsBMC Health Services Research, 2011
- Ambulatory health services utilization in patients with dementia - Is there an urban-rural difference?International Journal of Health Geographics, 2010
- Polypharmacy in Older Adults with CancerThe Oncologist, 2010
- Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in GermanyInternational Clinical Psychopharmacology, 2010
- Prevalence of cholinesterase inhibitors in subjects with dementia in EuropePharmacoepidemiology and Drug Safety, 2008
- The evidence is not convincingInternational Psychogeriatrics, 2008
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationPLoS Medicine, 2007